Company Profile
The Cooper Companies Stock Price, News & Analysis
- Ticker:
- COO
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- United States
Stock performance
73.32 USD (-2.03%)
Close
Last updated: August 6, 2026
11.6B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, COO closed down 2.03% at $73.32. No new same-company headline was identified in the current news window.
Company overview
Global Medical Device Company
CooperCompanies is a global medical device company operating through CooperVision and CooperSurgical. Headquartered in San Ramon, California, it employs more than 15,000 people, sells products in over 130 countries, and reaches more than 50 million people annually.
CooperVision
CooperVision is a major participant in the contact lens market, providing products for routine vision correction and broader eye-health needs. Growth is supported by global myopia-management demand, contact-lens adoption, and product innovation.
CooperSurgical
CooperSurgical focuses on fertility and women’s health, including assisted reproduction, maternity care, and related medical services. The company has resolved most claims associated with the 2023 voluntary recall of embryo culture media as it continues evaluating strategic options for the business.
Global Scale and Portfolio Mix
The combination of vision care and women’s health gives CooperCompanies exposure to both recurring consumer demand and procedure-driven clinical markets. Its international distribution footprint supports product sales across more than 130 countries.
Future catalysts
CooperCompanies’ watchlist is contact-lens growth, myopia-management adoption, and continued execution in the fertility and vision franchises. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
- 01
CooperCompanies Announces Release Date for Third Quarter 2026
Source: The Cooper Companies
- 02
CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure
Source: The Cooper Companies
- 03
CooperCompanies Announces Second Quarter 2026 Results
Source: The Cooper Companies
- 04
CooperCompanies Appoints Paul Keel to its Board of Directors
Source: The Cooper Companies
- 05
CooperCompanies Announces Release Date for Second Quarter 2026
Source: The Cooper Companies
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of The Cooper Companies (COO)?
The Cooper Companies (COO) most recently closed at 73.32 USD, a -2.03% move versus the previous session.
What is the market cap of The Cooper Companies (COO)?
The Cooper Companies currently has a market capitalization of 11.6B USD on BioPharmSignal.
What does The Cooper Companies do?
Global Medical Device Company CooperCompanies is a global medical device company operating through CooperVision and CooperSurgical. Headquartered in San Ramon, California, it employs more than 15,000 people, sells products in over 130 countries, and reaches more than 50 million people annually. CooperVision CooperVision is a major participant in the contact...
On which exchange is COO stock listed?
The Cooper Companies (COO) is associated with NYSE, United States, MedTech.
What is Global?
Global Medical Device Company CooperCompanies is a global medical device company operating through CooperVision and CooperSurgical.
Which conditions is The Cooper Companies targeting with Global?
Global Medical Device Company CooperCompanies is a global medical device company operating through CooperVision and CooperSurgical. Headquartered in San Ramon, California, it employs more than 15,000 people, sells products in over 130 countries, and reaches more than 50 million people annually. CooperVision CooperVision is a major participant in the contact...
How does The Cooper Companies describe recent progress with Global?
CooperCompanies’ watchlist is contact-lens growth, myopia-management adoption, and continued execution in the fertility and vision franchises. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers...
What is Medical?
Global Medical Device Company CooperCompanies is a global medical device company operating through CooperVision and CooperSurgical.